baber/WOPTO huggingface dataset:
Patent AT-E309349-T1 (AT)
Inventor: GRAY PATRICK W
IPC: G01N33/50
Filed: 1996-12-20
Granted: 2005-11-15
Abstract: The present invention provides polynucleotides that encode the chemokine receptors 88-2B and materials and methods for the recombinant production of these chemokine receptors. Also provided are assays utilizing the polynucleotides which facilitate the identification of ligands and modulators of the chemokine receptors. Receptor fragments, ligands, modulators, and antibodies are useful in the detection and treatment of disease states associated with the chemokine receptors such as atherosclerosis, rheumatoid arthritis, tumor growth suppression, asthma, viral infection, AIDS, and other inflammatory conditions.
Patent AT-E204940-T1 (AT)
Inventor: GRETEN ALFONS
IPC: E04B9/06
Filed: 1997-01-09
Granted: 2001-09-15
Abstract: The rail (1) has two pairs of parallel opposite profile arms (3,4,5,6). A central rib extends vertically between them, where there is also an accommodation space (7) for the edge of a cladding plate. The one pair's profile arms (3,4) have elastically pliable spring strips (11) on their outer edges (10) directed towards the other pair's arms (5,6), which reduce the size of the accommodation space. The rail is formed from an extruded plastics profile body, on which the spring strips are formed in one piece.
Patent AT-E267247-T1 (AT)
Inventor: UHLMANN EUGEN DR
IPC: C12N15/09
Filed: 1997-05-12
Granted: 2004-06-15
Abstract: The invention relates to enzymatic RNA molecules which cleave mutant N-ras mRNA, preferably at a NUX cleavage site (N = any base, X = A, C or U), having preferably the sequences  5'-CCAACACCUGAUGAGCGUUAGCGAAACCUGCU-3' or  5'-UCCCAACCUGAUGAGCGUUAGCGAAACACCUG-3', modified derivatives thereof, pharmaceuticals containing such molecules and use of such molecules for the preparation of pharmaceuticals for the treatment of diseases involving abnormal cell growth and/or differentiation. <IMAGE>
Patent AT-E203126-T1 (AT)
Inventor: FADLER GEORGES DIPL-ING
IPC: H05K5/02
Filed: 1997-10-30
Granted: 2001-07-15
Abstract: The open-air housing (10) has a frame for supporting the telecommunications apparatus, fitted to a socket (2), with a socket base. A further frame with a respective socket and socket base can be combined with the first frame, both enclosed by common housing panels, providing housing sidewalls (8), a roof (11) and access doors (9).
Patent AT-E217851-T1 (AT)
Inventor: LESKINEN ARTO
IPC: B65H18/10
Filed: 1997-06-11
Granted: 2002-06-15
Abstract: The invention concerns a method in winding of a paper web, in which method the paper web (W) is unwound from a paper reel (10) and in which method the paper web (W) is slit in a slitter-winder (30) longitudinally into component webs (Wn), which component webs (Wn) are further wound into component rolls. The paper web (W) is passed through the slitting station (40) of the slitter-winder (30), in which slitting station component webs (Wn) are slit out of the web (W) by means of blades (44), and the ends of the slit component webs (Wn) are cut off in a cutter device (45) into predetermined measures before the component webs (Wn) are passed into the winding stations. The winding device in winding of a paper web or equivalent comprises an unwind station (10) and a slitter-winder (30), which includes a slitting station (40), a cutter device (45), and the winding stations for component rolls. The cutter device (45) of the slitter-winder (30) includes an arrangement for cutting the component webs (Wn) into predetermined measures. <IMAGE>
Patent AT-E202196-T1 (AT)
Inventor: WINTRICH FRANZ DIPL-ING
IPC: F23N5/08
Filed: 1997-04-15
Granted: 2001-06-15
Abstract: The method involves transferring fuel into the boiler (1) which is burned by forming a flame (3) in a burner (2). Formation of the flame is detected by a detector using a small-area high spectral resolution CCD camera. The flame is regulated depending on the processing of detector output signals in a computer unit (9) by varying burner control parameters at the burner and/or at a device connected in series with the burner. The flame is detected by sensor with high spatial resolution and low spectral resolution and a sensor with low spatial resolution and high spectral resolution..
Patent AT-E225429-T1 (AT)
Inventor: SCHOERLING STEFAN
IPC: A47G25/06
Filed: 1997-01-09
Granted: 2002-10-15
Abstract: A domestic article, for example a valet, a lamp foot, a curtain rod, or a curtain tie back is bent into shape from a straight and stiff but bendable rope. The rope is made up of a steel tube as a core around which a number of strands of hemp or the like are firmly twisted simultaneously with each strand being firmly twisted around itself. The ends of the strands are firmly fixed to the tube and because of the frictional interaction between the strands and the core, the rope will be stiffer than the core. The rope will be bendable and the tube will substantially maintain its cross section in the bends.
Patent AT-E258358-T1 (AT)
Inventor: DENNERT THOMAS
IPC: H04M3/44
Filed: 1997-03-01
Granted: 2004-02-15
Abstract: The method involves allowing the subscriber to inform the operator of a limited number of destination address numbers, for which a special accounting tariff is to used. The subscriber places an individually selected destination address number in a database service node, with selection of a network internal service identity. A short call number associated with the address number can be selected by the subscriber as often as required. Subsequently the destination address number is identified and used to set up a link. All of the speech exchanged under the short number is accounted at the associated special tariff.
Patent AT-E245520-T1 (AT)
Inventor: SCHAD ROBERT D
IPC: B29C45/64
Filed: 1997-10-29
Granted: 2003-08-15
Abstract: A securing/clamping system for use with platens of a molding machine including a stationary platen (12) having a first mold half (24) affixed thereto, a movable platen (14) having a second mold half (22) affixed thereto, the movable platen (14) travelling along a plurality of tiebars (18), and reciprocatively moving between a mold open and mold closed position, and a system (10) for applying a clamping force to the movable platen (14).
Patent AT-E194104-T1 (AT)
Inventor: SUESS JOACHIM
IPC: B41M5/025
Filed: 1997-02-10
Granted: 2000-07-15
Abstract: In a process for the production of a stamping foil such as a hot stamping foil having a decorative layer provided on a carrier film only in a region-wise manner, corresponding to a desired patterning of the substrate, negative regions of the decorative layer, which do not remain on the carrier film, are removed from the carrier film of the stamping foil by being pulled off by means of a recipient foil.
Patent AT-E184696-T1 (AT)
Inventor: INSALACO JEFFREY LEE
IPC: B21D39/00
Filed: 1997-04-08
Granted: 1999-10-15
Abstract: A method and tool for installing a baffle in a tubular member, such as a heat exchanger manifold. The method and tool are adapted to use a baffle having a closed base that acts to obstruct the flow of a fluid within the tubular member, and further having a sidewall extending axially from the perimeter of the base so as to form a recess in the baffle. The tool is generally composed of a sleeve having an elastically and radially deformable end, such as a number of cantilevered members adapted to be elastically bent radially outward. Radially outward deformation of the sleeve enables the sleeve to securely grip the baffle, maintain the orientation of the baffle during its insertion into the tubular member, and then plastically deform the sidewalls of the baffle in order to secure the baffle to the wall of the tubular member.
Patent AT-E329602-T1 (AT)
Inventor: ROLF JOHN M
IPC: A61K38/16
Filed: 1997-06-18
Granted: 2006-07-15
Abstract: Method for obtaining highly purified transferrin from a partially purified plasma fraction containing transferrin in which the starting fraction is concentrated. Its ionic strength is reduced and then transferrin is adsorbed onto a chromatographic column. Following elution, the transferrin can be further processed through to packaging in final containers. The final purified transferrin product is sterile, at least 95% pure and is substantially free of enveloped and non-enveloped viruses.
Patent AT-E242127-T1 (AT)
Inventor: GUNNARSSON MATS
IPC: B41J2/175
Filed: 1997-08-04
Granted: 2003-06-15
Abstract: The invention concerns an arrangement for the automatic setting of printers, and more particularly the setting of printer parameters by means of code reading, and materials therefor. The parameters concern the printer work parameters, data communication, or printing layout. The code to be read may be applied directly onto the material to be used in the printer, or on separate sheets or labels. With the invention, an optimum setting of the printer (1) is automatically achieved, entailing high quality and making the printer easily usable also by unqualified personnel. The arrangement comprises a printing mechanism (2) and a control unit (3) for achieving a print-out on a printing material by means of a dye. According to the invention, a code reader (4, 5) is connected to the control unit (3) for reading a code for controlling at least one parameter of the printer means. The code may alternatively be associated with the receiver material, the dye, a peripheral device of the printer means, or a printing layout. <IMAGE>
Patent AT-E208214-T1 (AT)
Inventor: KOLBERG REINER
IPC: A61L2/06
Filed: 1997-08-01
Granted: 2001-11-15
Abstract: PCT No. PCT/DE97/01671 Sec. 371 Date Feb. 2, 1999 Sec. 102(e) Date Feb. 2, 1999 PCT Filed Aug. 1, 1997 PCT Pub. No. WO98/05366 PCT Pub. Date Feb. 12, 1998A production process for a prefilled, sterile syringe comprising providing a sterilized syringe barrel having sealable proximal and sealable distal ends. The proximal end being opened and the distal end being closed and adapted for coupling with a syringe outlet piece. In accordance with the process, the distal end of the barrel is closed and the barrel is then filled through the proximal end while the proximal end is opened with a fluid medium in the form of a liquid, a solution, a suspension or an emulsion wherein the barrel contains the fluid medium in a portion of the barrel and contains a gaseous medium in another portion of the barrel. After the barrel has been filled, a sterile plug is inserted through the proximal end of the barrel to close the proximal end. After pressing the plug into the barrel, the barrel is vented through a tube extending past the plug so that only the liquid medium is within the barrel. In accordance with one embodiment of the production process, the barrel is filled first through the open proximal end and then subsequently through a tube which extends past the plug.
Patent AT-E229586-T1 (AT)
Inventor: BURROW THOMAS RICHARD
IPC: D06M11/00
Filed: 1997-09-02
Granted: 2002-12-15
Abstract: Fabric comprising yarns comprising lyocell fibres is treated with a swelling agent, preferably aqueous sodium hydroxide, whilst in a form in which it is unrestrained and free to shrink. The swelling agent causes the lyocell fibres to swell without destroying their structure by dissolution, the amount of swelling being in excess of the amount to which the lyocell fibres will swell during exposure to all subsequent wet processing of the fabric. The effect of the swelling agent is then diluted with water so as substantially to set the yarns in the fabric in the positions relative to one another that they have in the swollen condition. The resulting fabrics are very much less affected by creasing than untreated fabrics are and do not suffer as much from the formation of lines during subsequent wet processing.
Patent AT-E243336-T1 (AT)
Inventor: DAVIS SCOTT H
IPC: G06F12/00
Filed: 1997-11-21
Granted: 2003-07-15
Abstract: Distributed shared memory systems and processes that can connect into each node of a computer network to encapsulate the memory management operations of the connected nodes and to provide thereby an abstraction of a shared virtual memory that can span across each node of the network-and that optionally spans across each memory device connected to the computer network. Accordingly, each node on the network having the distributed shared memory system of the invention can access the shared memory. <IMAGE>
Patent AT-E231300-T1 (AT)
Inventor: THOMPSON MALCOLM
IPC: H02G3/06
Filed: 1998-02-06
Granted: 2003-02-15
Abstract: A trunking or like component is disclosed comprising an open body having a flat base 11 and upright sides 12, 13 extending between at least two generally rectangular openings defined on three sides thereof by the base 11 and upright sides 12, 13. A lid 17 is adapted to close the open body, and a cover plate 23 overlies the junction between one end of the lid 17 and the end of an aligned adjacent lid 18. Rotary locking means comprising a turn buckle 25 is provided to both secure the cover plate 23 to the lid 17 and the lid 17 to the body. <IMAGE>
Patent AT-E410182-T1 (AT)
Inventor: L ITALIAN JAMES
IPC: A61K9/08
Filed: 1998-01-09
Granted: 2008-10-15
Abstract: The present invention is concerned with a pharmaceutical formulation in a container, for example, a vial, prefilled cartridge, prefilled syringe or disposable pen, comprising approximately 0.01 to about 0.5 % (w/v) amylin agonist, preferably pramlintide, in an aqueous system along with approximately 0.02 to about 0.5 % (w/v) of an acetate, phosphate, citrate, or glutamate buffer to a pH of the final composition of approximately 3.0 to about 6.0 as well as approximately 1.0 to 10 % (w/v) of a carbohydrate or polyhydric alcohol tonicifier; and, optionally, approximately 0.005 to 1.0 % (w/v) of a preservative selected from the group consisting of m-cresol, benzyl alcohol, parabens and phenol. These formulations maintain stability upon storage under refrigerated or room temperature conditions. Such formulations can be further combined with insulin in the same syringe for administration to a patient.
Patent AT-E292972-T1 (AT)
Inventor: SIMON SANFORD R
IPC: A61P11/00
Filed: 1998-02-26
Granted: 2005-04-15
Abstract: A method for inhibiting the activity of serine proteinase in biological systems includes administering to the system a serine proteinase inhibitory amount of a hydrophobic 4-de(dimethylamino)tetracycline. The method reduces tissue destruction during inflammation resulting from the activity of human leukocyte elastase. The method is used for pharmaceutical and cosmetic purposes.
Patent AT-E461374-T1 (AT)
Inventor: SCHLEGEL UDO
IPC: F16C33/10
Filed: 1998-07-20
Granted: 2010-04-15
Abstract: Bearing shells are inserted into the connecting rod eyes of connecting rods in internal combustion engines. The insertion of the bearing shells increases the complexity of the production process which can lead to errors being made. The aim of the invention is to provide a method for producing connecting rod bearings which are easier to install. According to the invention, a microporous aluminium bronze plasma-coating is applied to the large connecting rod eye (3). The connecting rod eye is then opened by removing the bearing cover (9), thus breaking the plasma coating (16). The cover (9) is subsequently screwed back on and the actual lining finished by fine spindling. The plasma coating (16) has an annular groove (32) to improve the oil retention volume. The invention is suitable for use in internal combustion engines.
Patent AT-E211379-T1 (AT)
Inventor: LEMAITRE JAQUES
IPC: A61F2/00
Filed: 1998-10-06
Granted: 2002-01-15
Abstract: The cement for surgical purposes includes three components. The first component includes beta tertiary calciumphosphate beta-Ca3(PO4)2(beta-TCP) particles; and monocalcium phosphate Ca(H2PO4)2(MCPA) or monocalcium phosphate monohydrate Ca(H2PO4).H2O (MCPM) particles or phosphoric acid. The second component includes water. The third component includes particles having an average diameter which is larger than the average diameter of the beta tertiary calciumphosphate beta-Ca3(PO4)2(beta-TCP) particles of the first component. Upon mixing of the three components a hardened mass comprising brushite CaHPO4.2H2O (DCPD) is formed. The beta-TCP particles have a specific surface area of less than 10,000 m2/g and a Ca/P atomic ratio different from 1.50. The component constitutes 1 to 99 volume-percent of the hardened mass. The cements according to the invention may be used in dental and maxillofacial surgery (alveolar ridge reconstruction, dental socket filling), for orthopaedic applications (bone fracture repair, bone augmentation) and for local drug delivery (antibiotics, anti-inflammatory and anti-cancer drugs).
Patent AT-E366521-T1 (AT)
Inventor: JEROME DARIA
IPC: A01K67/00
Filed: 1999-03-17
Granted: 2007-08-15
Abstract: Compositions and methods of using conjugated linoleic acid preparations enriched for the t10,c12 and c9,t11 isomers are disclosed. It is found that preparations of conjugated linoleic acid containing a ratio of t10,c12 to c9,t11 of about greater than 1.2:1 are desirable for a wide variety of nutritional, therapeutic and pharmacologic uses.
Patent AT-E274832-T1 (AT)
Inventor: ROSENBAUER MICHAEL
IPC: A47L15/42
Filed: 1999-12-16
Granted: 2004-09-15
Abstract: The unit has a door with inner (6) and outer parts and a control panel with at least one internal component (14) and at least one component that can be operated and/or seen externally. For old mounting types only one basic unit is provided still with an identical inner door and the arrangement of the internal component (s) is selected so that the externally visible component can be arranged to be operated and/or seen from several levels of the housing without altering the internal component(s).
Patent AT-E378143-T1 (AT)
Inventor: MALIE ANDRE HUBERT LOUIS
IPC: B23K20/00
Filed: 1999-07-12
Granted: 2007-11-15
Abstract: A mono-component brazing powder (5) is used for a brazing-diffusion process of superalloy parts (1,2) and comprises preparing superalloy powder of the same composition as the parts and 0.1-40 wt.% of a powder of at least one fluxing element (7) chosen in the boron and silicon group. Brazing-diffusion process of superalloy A parts comprises: (a) preparing superalloy A powder of the same composition as the parts and 0.1-40 wt.% of a powder of at least one fluxing element chosen in the boron and silicon group; (b) mixing the powders, and adding beads in a container; the beads and the container are made of a superalloy A, closing the container and maintaining under controlled atmosphere; (c) placing the container in a crusher and moving the container for 30 s- 500 h in order to incorporate the fluxing element in the surface of the superalloy powder grains; (d) cleaning in a chemical bath the parts surface to be brazed; (e) heat treating by thermochemical treatment the parts; (f) depositing on the parts surface the monocomponent powder obtained in the step (c); (g) performing a thermal cycle of oven brazing comprising ramping the temperature in stages up to a brazing temperature of 1050-1400 degrees C determined according to the superalloy and holding for 15-30 minutes; and (h) diffusion by thermal treatment in an oven under controlled atmosphere for 4-16 hours.
Patent AT-E200825-T1 (AT)
Inventor: BELLEVILLE DENIS
IPC: F41J2/02
Filed: 1999-12-03
Granted: 2001-05-15
Abstract: The target includes a module (141....1414) resting on a support and forming a strip and containing a structure support (20,21,28) on which rests a layer of an electrically conducting material (31,33). Two electrodes may generate a potential difference between them. At least two longitudinal faces (29,30) of each module are painted with different colors. A device (22,23) imparts rotation entire or a part of the modules to position on or other of the longitudinal faces on the front face of the target.
Patent AT-E259008-T1 (AT)
Inventor: MIDDELJANS HENDRIK
IPC: D01F6/30
Filed: 1999-02-09
Granted: 2004-02-15
Abstract: The invention pertains to a process for preparing thermoplastic fibres by melt-spinning an alternating co-polymer composed of alkenes and carbon monoxide in which the polymer is heated to a temperature of at least TNF+5° C., with TNF being the temperature at which the molten polymer is free of crystallization nuclei, and where the residence time of the polymer at a single temperature or different temperatures above the polymer melting point satisfies:wherein tn is the residence time (in minutes) of the polymer at a temperature Tn (in K, with Tn>Tm) and A and B are determined by measuring the viscosity of the polymer at different temperatures and residence times.
Patent AT-E246666-T1 (AT)
Inventor: HEIKKILAE HEIKKI
IPC: A23G3/00
Filed: 1999-05-17
Granted: 2003-08-15
Abstract: The invention relates to a novel process for the crystallization of xylitol by contacting a xylitol solution with particulate xylitol suspended in a gas, drying the material to produce a multitude of microrystals and conditioning the material into an agglomerated product. The invention also relates to a particulate crystalline xylitol product having novel properties, to the use thereof in confectionery, foodstuff pharmaceuticals and oral hygiene products, and to special products comprising the same.
Patent AT-E384126-T1 (AT)
Inventor: EGOROV ANDREJ Y
IPC: C12N15/09
Filed: 1999-06-11
Granted: 2008-02-15
Abstract: The present invention relates to genetically engineered attenuated viruses and methods for their production. In particular, the present invention relates to engineering live attenuated viruses which contain a modified NS gene segment. Recombinant DNA techniques can be utilized to engineer site specific mutations into one or more noncoding regions of the viral genome which result in the down-regulation of one or more viral genes. Alternatively, recombinant DNA techniques can be used to engineer a mutation, including but not limited to an insertion, deletion, or substitution of an amino acid residue(s) or an epitope(s) into a coding region of the viral genome so that altered or chimeric viral proteins are expressed by the engineered virus.
Patent AT-E463255-T1 (AT)
Inventor: WANG CHANG
IPC: A61K38/00
Filed: 1999-06-21
Granted: 2010-04-15
Abstract: The present invention is directed to novel artificial T helper cell epitopes (Th epitopes) designed to provide optimum immunogenicity when used in peptide immunogens comprising B cell epitopes or peptide haptens, a target antigenic site of a target antigen for eliciting antibodies thereto. The artificial Th epitopes are covalently linked to the target antigenic site and optionally an immunostimulatory sequence to provide effective and safe peptide immunogens.